French Society of Nephrology, Paris, France, February 1, 1979  by unknown
94 Abstracts
untraced. To date, 104 questionnaires and 73 ECGs have been
completed. For each sex and age decade, the incidence of angi-
na, intermittent claudication, or ischemic ECG abnormality are
not significantly different from a control population. Known risk
factors for IHD were also assessed at follow-up. Hypertension
was present in 33% of the nephrotic patients. Total plasma cho-
lesterol was elevated in 34% and total plasma triglyceride in 19%.
High-density lipoprotein (HDL) cholesterol levels were, how-
ever, normal in all patients studied to date. Glucose tolerance
was not impaired. Thus after a mean follow-up of 4.9 years, an
increased incidence of cardiovascular disease could not be de-
tected in this predominantly middle-aged population of patients
presenting with nephrotic syndrome. Hypertension was signifi-
cantly increased, but HDL cholesterol levels were normal. Rou-
tine treatment of hyperlipidemia in unselected adult nephrotics
is not indicated.
French Society of Nephrology
Paris, France
February 1, 1979
New method of water treatment for hemodiatysis. A. Abadie, P.
Bee, J. M. Pub, J. L. Lacombe, F. Maiha, D. Marty, and M.
Muslin. Clinique Saint-Exupéry, Toulouse, France. Since July
1977, French pharmacopoeia has recommended that water used
in hemodialysis contain limited quantities of anions and cations.
With the exception of total demineralization and distillation, no
current procedure meets these specifications. Particularly con-
spicuous in this regard is the softening technique, which is ac-
ceptable with regard to cations but not with regard to anions.
However, this shortcoming can be eliminated by combining the
softening procedure with an anionic permutation reaction. All
anions, particularly those most prohibited, NO3-, NO2-, F-, are
eliminated from the water and replaced by equivalent quantities
of CH3COO ions. This reaction also occurs using an ion ex-
changer according to the equation:
RCH3COO- + F- -* RF- + CHCOO
Resin
Infiowing anionic salts are totally transformed into CH3COO-
ions. In addition, this anion is used for the dialysate at approxi-
mately 35 mEq/liter and its desorption in front of all water anions
is very easy. Regarding the technical aspects: (1) the process is
combined in the same column with softening resin, (2) the regen-
eration of the two functions is achieved simultaneously by means
of a sodium acetate brine. The obtained results, using a proto-
type, are presented along with a perspective concerning appli-
cation in hemodialysis and peritoneal dialysis.
HDL cholesterol as cardiovascular risk factor in uremia. F.
Delavelle, J. C. Tromberl, and G. Canarelli. Service de
Nephrologie, Centre Renal Ermilage, Evian les Bains, France.
HDL cholesterol levels were studied concurrently with 'stan-
dard" blood lipid analysis in 105 subjects subdivided into three
groups: (I) healthy subjects (34 cases), (2) patients with severe
renal failure (serum creatinine, 60 to 100 mg/liter) (18 cases), (3)
chronic hemodialyzed patients (53 cases). Hypertriglyceridemia
was a predominant feature in group 2 (22% of cases with a mean
range of 2.60 0.59 g/liter) and group 3 (21% of patients; mean
range, 2.40 0.75 g/liter). Its incidence was reduced in African
hemodialyzed patients but was not influenced by sex, age, or
carbohydrate and caloric intake (although triglycendemia was in
the normal range positively correlated with carbohydrate intake:
r = + 0.56, P < 0.01). Total blood cholesterol was normal in the
three groups, but HDL cholesterol and the cs//3 cholesterol ratio
was significantly reduced (P < 0.00 1) in groups 2 (respectively,
0.32 0.11 and 0.21 0.08 g/liter) and 3 (0.39 0.11 and 0.27
0.12 glliter) as compared to group 1(0.54 0.15 and 0.42 0.21
g/liter). This drop in cholesterol was more pronounced in males
but was not related to age, ethnic origin, or the presence of dys-
lipidemia according to Frederickson's classification (HDL cho-
lesterol, 0.42 0.14 g/liter in type IV dyslipidemia and 0.40 g/
liter in hemodialyzed patients without dyslipidemia). However,
we found a positive correlation (r = 0.80, P < 0.05) between
nerve conduction velocity and HDL cholesterol, and cholesterol
was significantly decreased (P < 0.01) in group 2(0.32 0.11 g/
liter) when compared to the dialyzed patients in group 3 (0.39
0.11 g/liter). We suggest that better adequacy of dialysis may de-
crease cardiovascular risk in uremic patients by increasing HDL
cholesterol serum level.
Continuous peritoneal dialysis in the treatment of end-stage re-
nal failure. M. Dratwa, P. Vereerstraeten, and C. Toussaint.
Départenent de NCphrologie, Cliniques Universitaires de Brux-
cues, Höpital Brugmann and Hôpital Erasine, Bruxelles, Bel-
gium. Three patients with end-stage renal failure with residual
creatinine clearance under 2 mI/mm were treated by continuous
peritoneal dialysis (CPD), as advocated by Popovich, with four
2-liter exchanges per day, 5 days per week. As each patient had
been previously treated by hemodialysis (HD) and/or inter-
mittent peritoneal dialysis (IPD), it was possible to compare the
efficiency of CPD to that of conventional methods. The table
shows the serum concentrations (mean + SEM) of urea, creati-
nine, uric acid, phosphorous, and proteins observed in the three
patients in the course of the different modes of therapy used.
Phosphorus
mg/dI
.Patient Urea
tng/dl
Creatinine
mg/dl
Uric acid
mg/dl
Proteins
g
Patient I (female, 73 yr)
IPD 208 days
CPD 22days
201 6.5
109 9.0
7.7 2,2
6.8 3.1
11.9 2.6
8.3 3.2
5.2 2.8
3.0 1.4
6.7 0.9
5.4 1.1
Patient 2 (female, 57 yr)
IPD ll6days
CPD 28 days
179 9.0
56 5.0
11.0 0.4
6.1 0.3
10.7 0.6
5.5 0.3
4.1 0.3
2.0 0.2
6.1 0.3
4.9 0.1
Patient 3 (male, 59 yr)
HD 335 days
IPD 82 days
CPD 28 days
157 9.7
181 15.8
63 7.6
14.3 8.1
16.0 7.4
8.1 3.6
11.2 6.6
14.0 4.4
6.7 2.3
5.7 4.9
5.6 3.2
3.2 1.7
6.5 0.9
5.7 2.0
4.4 1.8
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As demonstrated by Popovich and by Oreopoulos, CPD was
very efficient for the removal of small molecules. It also con-
trolled very efficiently the sodium and water balances, leading to
rapid correction of arterial hypertension. All three patients
claimed that they had never felt so well with the other methods of
dialysis. The only untoward consequence of CPD was hypo-
proteinemia, resulting from protein leakage in the peritoneal
dialysate (8 to 20 g/day). CPD would potentially increase the in-
cidence of peritonitis but the periods of observation of our pa-
tients were too short to assess this point.
Idiopathic edema and intermittent venous compression in the
popliteal fossa. J. Fabre, P. Davanture, B. Krahenbuhl, A. Ros-
tan. Policlinique de médecine, Geneva, Switzerland. In an at-
tempt to elucidate the cause of idiopathic edema of legs, we in-
vestigated the occurrence of venous stasis with extension of the
knee in 51 patients complaining of edema and/or heaviness of the
legs without apparent cause, and in 39 comparable controls pre-
senting no complaint. None of these 90 subjects had a post-
phlebitic syndrome or deep venous obstruction. Variations of
calf volume were determined by mercury strain gauge around the
calf and connected to a sphygmomanometer. A first recording
was taken with the leg flexed 45° followed by one in complete
extension. In the control group, with the exception of one case,
extension caused no stasis in the leg. Twenty-six patients (51%,
P < 0.001) showed venous stasis as evidenced by an increase of
calf volume of 0.1 to 1.1% in approximately 30 sec. An identical
result was obtained by inflating a pressure cuff around the thigh
to 50 mm Hg on normal subjects. Injection of labeled fibrinogen
showed this increase of calf volume to be due to increase of
blood content. Auscultation of the popliteal vein by means of an
ultrasonic flow detector showed the venous flow to disappear in
extension in three fourths of all cases, with or without stasis.
Therefore, this study makes it possible to distinguish between
major obstruction to venous flow with resulting stasis and mere
compression of the popliteal vein. Arthrography of the knee was
carried out on 17 patients with stasis and revealed a popliteal
cyst in 9 cases of which only one could be suspected clinically.
Conclusion. In half of patients with idiopathic leg edema, exten-
sion of the knee causes stasis that was not found in the control
group. This finding is probably linked to anatomic changes of the
popliteal fossa that cannot be detected clinically. These patients
are best treated by rest with the knee semiflexed or by specific
treatment of popliteal cysts rather than by diuretics which too
often cause hyperaldosteronism.
Complement (C3) or IgG-Fc receptors and glomerular antigens
in tissue culture of normal glomerular cells. J. B. Foidart, C. H.
Dubois, J. M. Foidart, and P. R. Mahieu. Department of Medi-
cine, State University of Liege, Liege, Belgium, and NIDR, Be-
thesda, Maryland, USA. Recent methods have been described
for the cultivation of epithelial (A) and mesangial (B) cells de-
rived from normal human and rat glomeruli. The presence of C3
receptors on the surface membrane of each cell type has been
searched for using either fluoresceinated S. typhi bearing C3b or
sheep erythrocytes (SRBC) coated with activated C3. The pres-
ence of IgG-Fc receptors has been searched for using SRBC
coated either with IgG or with the (Fab')2 fragment of IgG. In an
attempt to further characterize the cultivated cells, immuno-
fluorescent microscopy studies were performed using antisera di-
rected against various antigens present in the normal glomerulus,
i.e., type-TV procollagen, noncollagenous glycoprotein, and fi-
bronectin. In the standard culture conditions, C3 binding sites
were detectable on human A cells only, the binding activity dis-
appearing within 5 days of culture. After incubation for 24 hours
in presence of aggregated immunoglobulins, C3 and IgG-Fc re-
ceptors were observed on human and rat B cells. These binding
activities were reversible. In these conditions, the A cells failed
to show a recovery of C3 binding sites. The antisera tested
stained, with various degrees of intensity, the surface membrane
of both A and B cell types. The data demonstrate that, in culture,
C3 or IgG-Fc binding sites and various glomerular antigens can
be observed on the surface membrane of both epithelial and
mesangial cells. They do not represent therefore adequate mark-
ers for the characterization of glomerular cells in culture.
0 and K antigenes of E. coli and renal injury in urinary tract
infection in adults. D. Fries, L. Renault, D. Mathieu, B. Char-
pentier, and L. Jacques. Department of Néphrology. Faculté de
Médecine Paris-Sud. Hópita/ Paul, Brousse, Villejuif France. It
has been suggested that renal injury during urinary tract infection
(UTI) could be the result of special pathogenicity of some E. coli.
In 138 adults with significant mono microbial F. coli UTI, IgG
antibody-coated bacteriuria (ACB) are correlated with three F.
co/i properties: somatic 0 antigen, capsular K antigen, and in
vitro resistance to Ampicillin. Antigens 06, 018, 022, are the
four serotypes most commonly found, and K3 K13 correspond to
half of the identified capsular antigens. In ACB+ patients com-
pared to ACB— subjects, a predominant 0 serotype is not found,
and K antigens are less frequently noted; nevertheless E. co/i 06
K'3 is found mostly in ACB+ patients. Resistance to Ampicillin
is more frequent in ACB± patients with K antigens, and espe-
cially in patients with rough strains, suggesting a modification of
the bacterial wall induced by antibiotics. The follow-up of these
three E. co/i parameters during relapses and reinfections shows
the complexity of the host-parasite relation. Conclusion. In
adults with UTI, the production of antibodies against F. co/i does
not correlate with 0 or K antigen, suggesting a lack of renal path-
ogenicity of these antigens, with the exception of F. co/i 06 K'3,
which remains to be confirmed in a larger series.
A new simple laboratory test demonstrating abnormal net Na4
and K fluxes in erythrocytes of essential hypertensives. R. P.
Garay and P. Meyer. INSERM U7, Hôpital Necker, Paris,
France. A new and simple laboratory test measuring net Na and
K4- fluxes in Na4--loaded/K4--depleted human erythrocytes has
been developed and applied to hypertension. Moderate essential
hypertension (10 patients) is characterized by a constant increase
in net K+ influx, possibly in relation to an increase in Na4--K4-
ATPase activity triggered by an increased net passive Na4- in-
flux. More severe cases (8 patients) present a decrease in net Na4-
effiux from erythrocytes, which may lead to a transitory or per-
manent increased intracellular Na content. MI essential hyper-
tensives were therefore characterized by a reduction of the ratio
of Na/K net fluxes. Conversely, Na4- and K erythrocyte
fluxes were found to be normal in hypertension of renal origin (5
patients), indicating that measurement of these parameters may
be useful in clinical practice. An alteration of erythrocyte K4-
influx was not observed in young normotensives born of normo-
tensive parents (17 cases) but appeared to be present inS out of 8
young normotensives born of essential hypertensive parents in
families where blood pressure has been recorded during three
generations. This result demonstrating a genetic transmission
suggests that measurement of Na and K erythrocyte fluxes
may help to detect subjects exposed to subsequent development
of high blood pressure. The alteration in net Na4- and K erythro-
cyte fluxes in essential hypertension is interpreted as a genetical-
ly transmitted membrane defect tending to increase intracellular
Na4- content, which in some excitable cells may be ultimately
responsible for the development of high blood pressure.
Antitubular basement membrane (TBM) antibodies detected by
radioimmunoassay (RIA): Incidence in human nephropathies and
correlations with histopathologic findings. P. Graindorge and P.
Mahieu. Department of Medicine, State University of Liege,
Liege, Belgium. We have recently set up a radioimmunoassay(RIA) for detection of anti-TBM antibodies. To evaluate the in-
cidence of anti-TBM antibodies in human nephropathies, we
tested the presence of anti-TBM antibodies by RIA in the serum
of 228 patients with various renal diseases. Fourteen percent of
the patients exhibited circulating antibodies to TBM. Patients
with positive results had interstitial nephritis (IN) and linear de-
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posits along the TBM only (6/6), glomerulonephritis (GN) with
linear GBM and TBM deposits (18/21), GN with linear deposits
along the GBM only (1/14), and GN with granular deposits (4/
135). Out of 52 patients with a renal allograft, 5 also exhibited
anti-TBM antibodies. To evaluate the possible role of the anti-
TBM antibodies, we studied renal tissue from patients with anti-
TBM antibodies and compared their tubulointerstitial lesions
with those found in patients without anti-TBM antibodies. The
following data were observed: (1) patients presenting circulating
anti-TBM antibodies and linear deposits along the TBM only ex-
hibited a moderate to severe TN, sometimes associated with giant
cells; (2) patients presenting circulating anti-TBM antibodies and
linear deposits along the GBM and TBM had severe IN; (3) the
interstitial lesions observed in the other groups of patients were
comparable, without correlations with the RIA. The data suggest
that only the anti-TBM antibodies found in IN with linear TBM
deposits may potentiate or contribute to the development of the
tubular disease.
Urinary elimination of lithium: Drug interactions. J. L. Imbs,
L. Singer, J. M. Danion, M. Schmidt, and M. Sebban. Service
d'Hypertension et institut de Pharmacologic, Service de Psychi-
atric, Strasbourg, France. Phenylbutazone treatment can lead to
intoxication by lithium salts. This observation has led us to in-
vestigate urinary elimination of lithium in animals: (1) On isolat-
ed perfused rat kidney, the fractional reabsorption (FR) of lith-
ium is correlated with that of sodium (r = 0.63; P < 0.001; N =
67). (2) In the conscious rat, phenylbutazone (P, 100 mg/kg) and
indomethacine (I, 2.5 mg/kg) increase the FR of lithium, whereas
hydrocortisone (H, 10 mg/kg) and methylhydrocortisone (MH, 3
mg/kg) reduce it. Lysine acetylsalicylate (AS, 80 mg/kg), amino-
pyrine (AM, 43 mg/kg), and sulfinpyrazone (S, 6 mg/kg) do not
significantly reduce the urinary elimination of lithium.
62 73
(10) (11)
where CL1 = lithium clearance (in jslimin/100 g body weight),
%R = percentage of tubular reabsorption of filtered lithium, and
parentheses show the standard deviation. (3) In the anesthetized
dog (pentobarbital), intrarenal perfusion of theophylline (2.4 to
4.8 mg/kg in 15 mm) increases natriuresis and lithium clearance.
These findings suggest that any drug capable of influencing the
proximal tubular reabsorption of sodium may affect the urinary
elimination of lithium.
Irreversible renal failure (RF) after indomethacin in steroid re-
sistant nephrosis (SRN). C. Kleinknecht, M. Brayer, J. B. Pal-
coux, M. C. Gubler. Hópital des Enfants-Malades, Paris,
France. After randomization, either chlorambucil (C) (0.2 mg/kg/
day) or indomethacin (I) (3 mg/kg/day) was given for 6 months to
two groups of 15 children with SRN, i.e., with persisting neph-
rotic syndrome (NS) after prednisone (2 mg/kg) administered
during at least 5 weeks. An early renal biopsy disclosed, in
groups C and I, respectively: 5 and 4 minimal glomerular
changes, 6 and 8 focal hyalinosis, 4 and 2 mesangial proliferation
with hyalinosis. Age, sex, previous duration of the disease, and
total follow-up were comparable in the two groups. After C, 4
patients underwent remission and 11 patients had persistent NS.
After I, 4 patients had remission, 9 had persisting NS, and GFR
decreased in 2, leading to terminal renal failure 3 and 9 months
after I was discontinued. Among the children with persistent NS,
10 children initially treated by C received I subsequently, and 8
children initially treated by I received C. Considering the two
cures of each therapy, the results were the following:
C 23
I 25
P < 0.02 2 test)
9 14 0*
7 12 6*
The Outcome was unrelated to the initial histopathological pat-
tern. Deterioration to TRF was unusually rapid in 4 patients
treated by I: 11, 25, 36, and 48 months after onset of the NS.
Conclusion. (1) The remission rate was similar after the two
drugs, and was possibly unrelated to treatment since 3 patients
remitted long after therapy was discontinued. (2) I seemed able
to induce or to accelerate an irreversible deterioration of renal
function in SRN, an effect which has been confirmed by a prelim-
inary experimental study. The mechanism of such deleterious ef-
fect remains to be elucidated.
Malignant histiocytosis revealed by a nephrotic syndrome
with acute renal failure. J. Lebas, A. Baumelou, C. Brocheriou,
M. Legrain. Service de Néphrologie and Service d'Anatomo-
pathologic, Groupe Hospitalier Pitié-Salpétrihre, Paris, France.
This clinicopathological syndrome has not yet been reported
in the literature. Heavy proteinuria and nephrotic syndrome
sets in abruptly in a 28-year-old male patient from Ivory Coast
with no previous medical history. Investigations for rheumatoid
factor, cryoglobulinemia, and circulating immune complexes are
positive. The nephrotic syndrome is rapidly followed by anuria
which requires treatment by peritoneal dialysis: the patient
dies, however, a few hours after being admitted in the De-
partment of Nephrology. Pathologic findings show a diffuse
infiltration of most organs (including the kidneys) by large multi-
nuclear histiocytic cells and medullary erythrophagocytis. The
overall structure of the lymph nodes is preserved. Histologic ex-
amination of renal tissue reveals optically normal glomeruli. Im-
munofluorescent studies do not show any deposits with Anti-
IgA, 1gM, Clq, C4, or C3 antisera. Such findings are similar to the
pattern of the nephrotic syndrome with minimal glomerular
changes which may be found in patients with lymphomas. The
origin of anuria remains unclear. The combined role of the hy-
povolemia induced by the nephrotic syndrome together with the
diffuse infiltration of the renal interstitial tissue by histiocytic
cells may be considered, since amyloidosis, renal vein throm-
bosis, ureteral obstruction, hypercalcemia, and hyperuricemia
were ruled out by clinical, biologic, and pathologic findings.
Increased risk of renal graft failure and immunopathologic find-
ings in le/le recipients. M. Levy, M. F. Gagnadoux, R. Oriol, and
M. Broyer. Hópital des Enfanis-Malades, Hópilal Broussais,
Paris, France. Lewis antigen types (Le, le) were determined in
97 transplanted children. Five patients were found to be le/le.
These five children underwent seven grafts. Although the donors
were not typed in the Lewis system, transplants were likely to
have been mismatched. Six out of seven were matched, however,
in the HLA system (< 2 incompatibilities). The five first grafts
N Remissions NS RF
C1.1
Control
(N = 55)
153
(70)
P I H MH AS AM
(N = 11) (N = 11) (N = 16) (N = 20) (N = 20) (N = 17)
65 64 225 321 141 181
(35) (31) (61) (170) (55) (129)
86 46 46 58 48
(5) (11) (14) (10) (17)
S
(N = 22)
181
(89)
65
(14)
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and a second graft either were rejected or have a poor function
(serum creatinine, > 2.0 mg/dl). In one patient, the second graft
is well functioning. Of the 85 Le recipients followed more than 3
months after transplantation, serum creatinine is> 2.0 mlldl in 8,
and 21 lost their first graft. Second grafts performed in six pa-
tients are still functioning. When all grafts are considered togeth-
er, the risk of graft failure is higher in le/le recipients (86%) than
it is in Le recipients (32%). Immunofluorescence microscopy of
repeat graft biopsies performed in four le/le recipients disclosed
in three patients (six biopsies) a linear staining of the glomerular
basement membranes (GBM) with anti-IgG antiserum. Circulat-
ing anti-GBM antibodies were detected by radioimmunoassay in
two of them. Such an immunofluorescent pattern has not been
observed in any of the 67 graft biopsies performed in 45 Le recip-
ients. We would therefore stress the importance of the Lewis
system in kidney graft survival. The relationship between Le an-
tigen types and the occurrence of anti-GBM antibodies remains
to be elucidated.
Development of malignant uroepithelial tumors in the upper un-
nary tract in patients with analgesic-associated nephropathy
(AAN): Clinical findings in 16 patients. W. Lornoy, V. Morelle, I.
Becaus, F. Fonteyne. Department of Nephrology and Urology,
0. L. Vrouwziekenhuis, Aalst, Belgium. According to the com-
bined report of the EDTA, 1977, AAN is the diagnosis in more
than 20% of patients with end-stage renal disease in Belgium.
During the last 5 years, 16 patients (8% of patients with AAN)
presented a transitional cell carcinoma in the upper urinary tract:
in nine cases a renal pelvic tumor, and in four cases a ureteral
tumor. Two patients were found with a tumor of both. Another
patient had a renal pelvic tumor, and 3 years later, on autopsy, a
renal cell carcinoma was detected in the contralateral kidney.
These cancers were not seen in patients with other types of ne-
phropathy. The cases of AAN with bladder tumor were omitted
because of the high incidence of bladder cancer. Painless gross
hematuria or renal colic were the most common symptoms. The
mean serum creatinine was 6, 5 mg/tOO ml (0.9 to 12 mg/l00 ml).
Hydronephrosis was seen in seven cases and a nonfunctioning
kidney in four cases. Urine cytology and retrograde pyelography
proved to be of great diagnostic value. A total nephroureterec-
tomy was carried out in 11 patients. Three were treated with he-
modialysis. Five others were inoperable. Five patients are still
alive, but in one metastases are present.
Chronic hypernatremia and partial hypopituitarism in sar-
coidosis. J. C. Laciani, B. Conte-Devolx, C. Marty-Double, J.
Fourcade, P. Barjon. Service de Médecine D, Hdpital St
Charles, Montpellier, France. A syndrome of chronic hyper-
natremia (mean SEM, 154 1.3 mmoles/liter; N = 12; range,
148 to 161) and hypodipsia, with partial hypopituitarism (growth
hormone and gonadotropin deficiencies) is reported in a 27-year-
old man with sarcoidosis and hypothalamic involvement. The
hypernatremia appeared to be due both to a disorder of the thirst
mechanism and to an abnormal osmotic control of vasopressin
(AVP) release. Spontaneous fluid intake was variable (700 to
2400 mI/day), and abnormal when considered relative to the pa-
tient's elevated plasma osmolality (POsm). When larger amounts
of water were given (50 mI/kg for 180 mi, POsm returned to
normal values in 3 hours. Plasma AVP concentrations (< 1 to 1.9
pg/mI) were inappropriately low for the degree of POsm (312
3.0 mOsm/kg) and remained markedly subnormal when hyper-
tonic saline was infused (NaCI 5%, 10 mI/mm for 60 mm). How-
ever, the secretory stores and hemodynamic control of AVP re-
lease were intact because a rise in plasma AVP to 10.8 pg/mI was
observed after induction of arterial hypotension with sodium ni-
troprusside infusion (1.5 and 3.5 g/kg/min). Autopsy findings
revealed sarcoidosis involving the preoptic hypothalamic region.
There was no involvement of the pituitary itself. These results
confirm that the thirst and osmoreceptor mechanisms are ana-
tomically distinct from the AVP secretory system and its barore-
ceptor regulation.
Renal glomerular complement (C3) receptors in E. coli-injected
rats. F. J. Mathieu, J. B. Foidart, C. H. Dubois, G. J. Fournié,
and P. R. Mahieu. Department of Medicine, State University of
Liege, Liege, Belgium, and Laboratory of Renal Immuno-
pat hology, C. H. U. Toulouse Purpan, Toulouse, France. A sus-
pension of 10 F. coli (0.55, INRV, Brussel) was injected, in the
urethra or intraperitoneally, into Sprague-Dawley rats weighing
about 150 g. The C3 receptor binding activity was measured us-
ing either fluoresceinated S. typhi bearing C3b or sheep erythro-
cytes coated with activated C3. The following data were ob-
tained: (1) the rats injected in the urethra developed a pyelone-
phritis, whereas the rats injected intraperitoneally developed a
glomerular disease; (2) granular IgG and C3 deposits were only
observed in the glomeruli from the rats injected intra-
peritoneally; (3) no staining of the glomeruli was observed using
specific fluoresceinated rabbit anti-E. coli antibodies, but the
renal interstitium from the rats injected in the urethra was strong-
ly stained by the same antibodies; (4) no glomerular C3 receptor
binding activity (BA) was detectable in normal rats or in the rats
injected in the urethra; (5) such a BA was found, focally, in the
glomeruli from the rats injected intraperitoneally; (6) the BA ap-
peared after about 7 days; (7) comparable results were obtained
using both indicator cells; (8) control indicator cells, which did
not contain activated C3, failed to bind to the glomeruli. The
results suggest that C3 receptors are present, but probably "la-
tent," in the normal rat kidney. The mechanisms by which they
become "accessible" to the indicator cells after the injection of
E. coli remain unknown.
Acute internal hemorrage due to spontaneous visceral ruptures
in hemodialysis patients. A. Meyrier, C. Verger, K. S. Ang, J. D.
Sraer, 0. Kourilsky, and J. P. Jablonsky. Service de
Néphrologie, Hôpital Tenon, Paris, France. Four hemodialysis
patients experienced acute spontaneous internal hemorrhage.
Two of them died rapidly or secondarily to this complication. In
case 1, acute hemoperitoneum led to rapid death during hemo-
dialysis. Autopsy disclosed a ruptured spleen abscess. In case 2,
acute hemoperitoneum occurred between two dialyses. Splenec-
tomy showed a ruptured splenic hemangioma. Angiography
ruled out other vascular localization. Case 3 was extensive retro-
peritoneal hemotoma in a patient dialyzed for chronic pyelone-
phritis with two small contracted kidneys. The bleeding came
from a small ruptured degenerative cyst of the renal cortex.
Death ensued from postoperative complications. Case 4 was
spontaneous intraperitoneal rupture of an infected spleen. There
was a perisplenic hematoma with a communication to the retro-
peritoneal space. These four cases share some common features:
(1) acute hypovolemia due to the spontaneous rupture of a solid
organ, (2) occurrence in hemodialysis patients, (3) absence of
systemic vascular disease such as polyarteritis nodosa, (4) no
concomitant bleeding disorder. In three cases there was a link
between (a) the renal disease and/or hemodialysis and (b) the
mechanism of the hemorrhage: twice the splenic infection was
probably a metastatic localization of unrecognized bacteremia.
In case 3, there was cystic degeneration of the kidney, a recently
described condition. The hemorrhage cannot therefore be con-
sidered as merely coincidental in the course of hemodialysis.
This unusual complication must thus be kept in mind among the
possible causes of hypovolemic shock and even of unexplained
sudden death in a hemodialysis population.
Middle molecules action on the level of cellular respiration from
uremic patients treated by hemodialysis. A. Murisasco, S.
Saingra, A. Grevat, J. B. Rinaudo, and P. Gallice. Centre de
Néphrologie, Hdpital Sainte-Marguerite, et Laboratoire de
Biophysique, Faculté de Pharmacie, Marseille, France. Middle
molecules were isolated according to the method devised by
Furst (chromatography by gel permeation and ion exchange)
from sera of uremic patients before hemodialysis sessions. The
7c peak (involved in various toxic processes) was collected and
lyophilized. It was then tested at a concentration of 1.8 mg/mI on
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mitochondrial respiratory activity. The experimental results
show that at this concentration the respiratory control (ratio of
oxidation velocity, with and without ADP) and the ratio ADP/
oxygen (amount of ADP converted into ATP per oxygen atom
consumed) decreased by 30%. The oxygen consumption neces-
sary for the synthesis of one ATP molecule increased by 40%
which lead to a lower efficiency of oxidative phosphorylation. It
is therefore concluded that one toxic effect of the 7c fraction is to
inhibit ATP synthesis. This induces a fall in the cellular ATP pool
available for the different energy-dependent metabolic process-
es. Such an approach may account for the various toxic effects of
middle molecules so far reported in the literature.
Radiologic and endoscopic aspects of the duodenal cap in chron-
ic uremia. M. Olmer, M. J. Treffot, J. Ducros, M. Lankester, A.
Monges. Hópital de la Conception, Marseille, France. In 78 pa-
tients with chronic renal failure treated by dialysis, we investi-
gated the upper digestive tract and we compared radiologic and
endoscopic findings. X-ray examination showed in 41 cases out
of 78 the following lesions: hiatus hernia (6), hypertrophic folds
of the gastric fundus (4), gastric or duodenal peptic ulceration
(4), polyp-like aspect of the duodenal cap (27) classified in two
stages: stage I, 'cloudy" aspect; stage II, well-defined polyp.
Fibroscopy was performed in 32 cases; it appeared normal in 5
cases and abnormal in the other 27 cases: lesions of the esopha-
gus (4), hyperplasic foldings of the gastric fundus (3), gastric or
duodenal peptic ulcer(S), and polyp-like aspect of the duodenal
cap (15). The latter changes were classified in 3 types: type I,
hypertrophic foldings with edematous aspect; type II, sessile
polyp-like aspect with edematous mucosa; type III, polyp-like
aspect with ulcerated and hemorrhagic mucous membrane. In
four patients these lesions were associated with ulcers. Twenty-
four of 32 patients had fiberoptic endoscopy and concomitant ra-
diologic examination. A discrepancy between the two investiga-
tions was found in eight cases, and endoscopy provided exact
diagnosis. In contrast, fiberoptic endoscopy furnished inexact
data in five other cases. In 11 patients the results of the two
methods were in agreement. Conclusion. Polyp-like aspect of the
duodenal cap is frequently found in uremic patients treated by
dialysis. Identical lesions were observed only in 41 alcoholic pa-
tients (i.e., 1.5% of 2600 patients submitted to endoscopy). We
found no significant correlation between these lesions and the
state of hydration, the levels of plasma gastrin, calcium, or phos-
phate, and the dialysis strategy. A hormonal mechanism, how-
ever, cannot be excluded.
Dialysis and transplantation in Wegener's disease. Y. Pirson, J.
C. Debongnies, J. Steyart, U. P. J. Alexandre, and C. Van Yper-
se/c de Strihou. Nephrology and Transplantation Unit, Cliniques
Universitaires St. Luc, and Department of Medecine, Clinique
Universitaire de Mont-Godinne, University of Louvain, Brus-
sels. Belgium. The prognosis of Wegener's disease (WD) has
been transformed by cytotoxic drugs. As a result, hemodialysis
(HD) followed by transplantation (TP) has been undertaken and
success has been reported in four patients. It is not clear, how-
ever, whether it is advisable to initiate HD and TP when the dis-
ease remains active despite cytotoxic therapy. Two males aged
43 and 34 years with characteristic WD (focal glomerulonephri-
tis, excavated lung tumors, and nose and ear lesions) received'
immunosuppresive therapy for 14 and 16 months, respectively,
initiated at a time of severe renal insufficiency; after initial im-
provement of renal function and regression of respiratory-tract
lesions, new lesions (nose ulceration in one case; uveitis and
mononevritis in the other) appeared, and renal failure pro-
gressed. HD was undertaken for 4 months and 13 months, re-
spectively, until TP. Despite interruption of cytotoxic drugs once
on HD and a decreasing steroid therapy, all signs of disease ac-
tivity disappeared with a resulting complete healing of extrarenal
manifestations of WD. At the present time, 11 and 53 months
after TP, respectively, renal function is satisfactory (serum
creatinine, 1.7 and 1.5 mg/dl, respectively). No signs of reactiva-
tion of WD have reappeared. These observations suggest that
HD and TP should be undertaken in the treatment of terminal
renal failure due to WD irrespective of the initial response to
immunosuppressive therapy.
Activity of a new high-ceiling diuretic in man: Piretanide (HOE
118). N. Pozet, A. Hadjaissa, M. Pellet, J. Traeger. Ildpital
Edouard Herriot, Lyon, France. Diuretic activity of Piretanide
(4-phenoxy-3-( l-pyrrolidinyl)5-sulfamoyl benzoic acid) was
studied in 16 patients with GFR (C inulin) varying from 7 to 147
mllmin. After hydration (10 mI/kg of body wt) and following two
control periods, a single dose of 6 mg of Piretanide was ingested.
Thereafter, urine was collected every 30 mm during 2 hours and
every hour the next 4 hours. Fluid losses were replaced with
water oral intake and isotonic saline and glucose infusion. Urine
flow rate (V), C inulin, CPAH, Curea, Ceeratinine, Curie acid, Ccnm,
C0,0; excretion rates of Na, Cl, K, Ca, P04, HCO3, NH4, titrable
acidity, and urine pH were evaluated. Plurifactorial analysis of
variance showed the following results: In the group with normal
GFR (C10 > 90 mI/mm), the maximum significative effect oc-
curred after 60 to 90 mm: mean maximal increase was 4.4 times
for V; 3.8 for Coum; 10.7 for UNOV; 10.9 for U1V; 2.7 for UKV;
fractional Na excretion increased to 12% and Na/K ratio to 9.2.
In the group with mild renal failure (60 <C10 <85 mllmin), the
effect was less pronounced but quite significant. C0,0 evaluation
in these two groups showed preservation of dilution capacity. In
the group with severe renal insufficiency (C10 < 17 mllmin), in-
creased parameters were not significant. In all subjects, no signifi-
cative change of C1,, and CPA!1 occurred. After a single oral intake
of 6 mg, Piretanide was thus a potent and effective salidiuretic,
and no change of GFR occurred in the subjects with no or mild
renal failure. This dose was ineffective in severe renal in-
sufficiency.
A new mode of treatment for end-stage renal failure (ESRF):
Continuous ambulatory peritoneal dialysis (CAPD). J. Rot-
tembourg, D. Jacq, A. Monteiro, and C. Jacobs. Service de
Nephrologie. Groupe Hospitalier Pitié-Salpétrière, Paris,
France. CAPD has been performed in six patients with ESRF
(three males and three females) aged 32 to 81 years (mean, 63
years) during a cumulative period of 40 patient-weeks. Two liters
of dialysate contained in a plastic bag (maximum content, 2.5
liters) are infused intraperitoneally five times daily, 7 days/week.
Intraperitoneal dwelling time is 4 hours for day-time exchanges
and 8 hours at night. The dialysate composition is as follows (per
liter): Na, 133 mEq; K, 1 mEq; Mg, 1.5 mEq; Ca, 3.5 mEq; ace-
tate, 30 mEq; Cl, 109 mEq; glucose, 15 or 45 g/liter. The clear-
ances of small molecules are the following: urea, 9.6 mI/mm;
creatinine, 9.3 mI/mm; uric acid, 7.8 mI/mm; phosphorus, 6.7 ml!
mm. The average plasma and creatinine levels of the patients
are, respectively, 50 mg/dl and 1 mg/kg body weight. Aluminum
phosphate binders could be withdrawn in four patients. Fluid re-
moval per cycle is 180 ml 110 when the dialysate contains 15 g!
liter of glucose and 500 ml 220 with 45 g/liter. With four ex-
changes with each 15 g/liter of glucose and one with 45 g, the
average daily fluid removal is 1220 ml (±330). The daily negative
sodium balance reaches 70 mEq (±25). The average daily protein
loss is 17 g (±3.2), i.e., around 120 g/week. The glucose con-
tained in the dialysate yields about 600 calories each day. One
episode of peritonitis due to a Gram-negative stain was recorded
in 1400 cycles, turbidity of the dialysis fluid with more than 500
cells/mm3 was observed five times. These incidents were treated
by continuous peritoneal lavage, with antibiotics being added to
the dialysate. These preliminary results indicate that CAPD is a
truly ambulatory, efficient, economical, and well-accepted meth-
od of treatment for patients with ESRF. The main drawbacks are
the high daily supply of glucose, the protein waste which makes a
high dietary protein intake mandatory, and the risks of peritoneal
infection if the numerous connections are not carried out under
utmost sterile conditions.
The mechanism of the renal glycosuria associated with the ne-
phrotic syndrome. A. Seiler and F. Reubi. Policlinique de
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Médecine, University of Berne, Switzerland. We have occasion-
ally observed normoglycemic glycosuria in patients with the
nephrotic syndrome. The purpose of this study was to investi-
gate the mechanism of this disturbance. In our series consisting
of three patients with extramembranous and three with mem-
branoproliferative glomerulonephritis, fasting glycosuria was
present in four. In all patients, clearance determinations with
glucose titration were performed. In the whole series, GFR
ranged between 15 and 92 mI/mm, TmG between 37 and 220 mg/
mm. In the two patients without glycosuria, the Tm/GFR ratio
was slightly above normal. In the four glycosuric patients, glu-
cose reabsorption increased with the load, so that the TmGIGFR
ratio ultimately reached normal values (2.31 to 2.81). Therefore,
this form of glycosuria appears to be similar to type B familial
renal glycosuria (Reubi, 1950). The low threshold may result
from the interference of the tubular lesions accompanying the
nephrotic syndrome with the affinity of one of the carriers for
glucose.
Role of the sialic acids of the glomerular basement membrane in
glomerular selective protein filtration: Study of the effect of neur-
aminidase on sialic acid release and albumin clearance by isolated
perfused rat kidney. M. Sternberg, W. Callaway, and W. Murfin.
Elliott P. Joslin Research Laboratory and Department of Medi-
cine, Harvard Medical School, Boston; Départeinent de Bio-
chimie, Faculté de Médecine, Université Lava!, Québec, Cana-
da. It has been suggested that glomerular basement membrane
sialic acid, by means of its negative charge, might play a role in
the selectivity of glomerular filtration of proteins. In experimen-
tal or human glomerulonephritis, sialic acid content of the gb-
merular basement membrane is decreased. Furthermore, in
nephrotoxic serum nephritis, there is increased clearance of neg-
atively charged dextrans (but not of neutral dextrans), consistent
with the observed decrease in colloidal iron staining of negative-
ly charged polysaccharides in the glomerular wall We have de-
termined the effects of neuraminidase from Vibrio cholerae, at a
final concentration of 66 U/mI, upon sialic acid excretion and
albumin clearance in the isolated perfused rat kidney. This sys-
tem avoids complicating systemic effects of neuraminidase, as
well as interactions with the various sialyl-glycoproteins of nor-
mal blood. Perfusion medium consisted of Krebs-Henseleit solu-
tion, containing 6% bovine serum albumin (fraction V), and a
mixture of substrates which had previously been found to sustain
stable renal function for at least 1 hour (glucose, 5 mr'.i; lactate,
2.5 mM; butyrate, 2.5 mM; and a mixture of nine amino acids
with individual concentrations ranging from I to 3 mM), but no
free or bound sialic acid, After a control period, neuraminidase
was added to the perfusion medium, and the perfusion was con-
tinued for 40 to 60 mm. Urine and perfusion medium samples
were obtained every 10 mm. Control kidneys were perfused in
parallel, but without addition of neuraminidase. Neuraminidase
increased sharply and significantly sialic acid excretion in the
urine up to 15 nmoles/min. In contrast, it produced no significant
change in protein excretion per minute, in albumin clearance, or
creatinine clearance. Neuraminidase activity remained fairly
constant in the perfusion medium; only a small percentage was
detected in the urine. Thus, under these experimental condi-
tions, no relationship between sialic acid removal from the kid-
neys and protein clearance could be demonstrated.
Renal toxicity in man treated with Mitomycin C: One case with
acute renal failure and histologic renal examination. G. Touchard,
D. Picaud, Ph. Babin, M. Baron, 0. Pourrat, and P. Nolen.
Service d'Anatomie pat hologique et service de Néphrologie
(C.H.R. Hotel Dieu, Poiters, and Service de Médecine D du C.
H. Georges Renon, Niort, France. A 58-year-old man was ad-
mitted in July 1978 for asthenia and dyspnea. BUN was 163 mg/
100 ml, and serum creatinine was 5.8 mg/100 ml. Seven months
earlier, he underwent a left colectomy for adenocarcinoma of
transverse colon followed by Vincristine treatment, 5 FU, and
Mitomycin C. Vincristine therapy was discontinued after 4
months because of polyneuritis. BUN was within normal range
before treatment. He received Mitomycin C, 0.53 mg/kg body
weight (total dose 32 mg), each month during 6 months. He de-
veloped acute renal failure with proteinuria and microscopic
hematuria. Histologic examination of left kidney biopsy showed
glomerular lesions with focal sclerosis, voluminous endo-
membranous clear deposits, and unusual degenerative changes
in many nuclei. Electron microscopy and immunohistology stud-
ies were also performed. Laboratory tests showed also thrombo-
cytopenia, anemia, hepatic cytolysis and decreased alveolar CO
diffusion. Renal failure was partially regressive. To our knowl-
edge this renal complication in association with hepatic and pul-
monary complications has not been reported previously. Cases
of renal toxicity and cases of pulmonary toxicity have been re-
ported.
Relative importance of the aldosterone and the natriuretic factor
in the maintenance of the sodium balance. M. Vonlanthen, F.
Louis, and H. Favre. Clinique Médicale, Division de
Néphrologie, Département de Médecine, HOpital Cantonal,
Genève, Switzerland. The key role of the distal segment of the
nephron in the maintenance of sodium balance has been recently
emphasized. Therefore, the relative importance of the aldoster-
one (A) and the natriuretic factor (NF) has been investigated. NF
was prepared from urine by fractionation through a G25 Seph-
adex column. Its activity was measured using a normal rat
bioassay (FENai). (a) Five students fed a 400 mEq Na diet per
day over a 10-day period were given 0.6 mg of 9 a fludrocorti-
sone (9 a F) from the sixth day. FENai was identical during the
control period (C) and the post escape period (E) (P < 0.2).
FENa significantly increased the day before the escape com-
pared to C (P < 0.05) and to E (P < 0.025) at a time where an
average of 277 41 mEq sodium were retained. (b) In a toad
bladder preparation, when short-circuit current (SCC) is stimulat-
ed by A, the NF still inhibits the sodium transport by 30%, a
value identical to that observed when the same fraction is applied
to a nonstimulated membrane. (c) The urinary kallikrein increas-
es on steroids by 127.53 21% (P < 0.0025) without any rela-
tionship with the return to an equilibrated sodium balance. How-
ever, kallikrein increase correlates with the degree of sodium re-
tention before the escape phenomenon occurs (P < 0.05).
Conclusion. In toad bladder preparation, previous stimulation of
the SCC by A does not modify the inhibitory activity of the NF.
In vivo, the escape phenomenon to the sodium retention induced
by A is determined by an increase of NF which plays a major role
in the return of an equilibrated sodium balance despite the main-
tenance of a high mineralocorticoid dose. In this system, kalli-
krein seems to be antinatriuretic rather than natriuretic.
Histopathologic findings and clinical course in 58 cases of ne-
phrotic syndrome in aged adults. P. Zech, S. Colon, P. Pointet,
N. Blanc, M. Labeeuw, and P. Deteix. Clinique de Nephrologie
et INSERM U80, HOpital Edouard Herriot, Lyon, France. Fifty-
eight cases of nephrotic syndrome occurring in adults over 60
years old were studied. Males were involved in 65% of cases
with edema as the chief complaint. Amyloidosis, lupus ery-
thematosus, multiple myeloma or renal vein thrombosis was
found in 33% of cases, no special cause being found in other
67%. Membranous nephropathy was present in 66% with coexis-
tent malignant tumor in 4 cases and renal vein thrombosis in 3.
Within 3 years of follow-up, 3 patients died, 2 were clinically
cured, 6 improved, 10 had no change. Minimal changes are ob-
served in 33% of cases. Under steroid treatment, healing was
complete in 66%, incomplete in 11%. Failure to improve oc-
curred in 5 patients, 3 of whom had multiple myeloma or pen-
arteritis nodosa. Proliferative glomerulonephritis (12%), amyloi-
dosis (13%), and gbomerular sclerosis (1 case) were more rarely
observed. Among the few series of nephrotic syndrome occur-
ring in aged adults, our study points out the relatively high in-
cidence of idiopathic nephrotic syndrome, of minimal change ne-
phropathy, and the occurrence of complete remission under ste-
roid therapy.
